• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal...

cafead

Administrator
Staff member
  • cafead   Nov 01, 2021 at 11:42: PM
via Over the last few months, Johnson & Johnson has made sweeping moves to resolve a mountain of litigation involving the safety and marketing of its opioid and talc products. Friday brought word of a lower-profile resolution, as J&J revealed it has settled liability claims surrounding its antipsychotic drug Risperdal.

article source
 

<